S Armstrong|W J Russell - JoVE Visualize

Showing results (491-500 of 888) with videos related to

Pageof 89

Sort By:

World Journal of Gastroenterology|July 5, 2005

Hydrogen sulfide protects colon cancer cells from chemopreventative agent beta-phenylethyl isothiocyanate induced apoptosisPeter Rose, Philip-K Moore, Shen-Han Ming, et al.

Annals of the Royal College of Surgeons of England|January 1, 1993

Will screening for breast cancer reduce mortality? Evidence from the first year of screening in AvonS Nicholson, A J Webb, B Coghlan, et al.

Traffic (Copenhagen, Denmark)|November 4, 2004

Ncr1p, the yeast ortholog of mammalian Niemann Pick C1 protein, is dispensable for endocytic transportShaochong Zhang, Jihui Ren, Hongzhe Li, et al.

Malaria Journal|March 20, 2013

T1BT* structural study of an anti-plasmodial peptide through NMR and molecular dynamicsElena Topchiy, Geoffrey S Armstrong, Katherine I Boswell, et al.

The Journal of Biological Chemistry|April 19, 2014

Residue histidine 50 plays a key role in protecting α-synuclein from aggregation at physiological pHYing-Chih Chi, Geoffrey S Armstrong, David N M Jones, et al.

Acta Radiologica (Stockholm, Sweden : 1987)|March 1, 1994

Ultrasonographic abdominal screening of atomic bomb-exposed subjectsW J Russell, Y Higashi, T Fukuya, et al.

Anaesthesia and Intensive Care|October 1, 1993

The Australian Incident Monitoring Study. Which monitor? An analysis of 2000 incident reportsR K Webb, J H van der Walt, W B Runciman, et al.

Vox Sanguinis|January 1, 1989

Influence of blood storage time and plasma histamine levels on the pattern of transfusion reactionsD B Frewin, J R Jonsson, C R Frewin, et al.

Antimicrobial Agents and Chemotherapy|February 2, 2011

Activity of ACHN-490 tested alone and in combination with other agents against Pseudomonas aeruginosaGlenn A Pankuch, Gengrong Lin, Aya Kubo, et al.

Journal of Cancer Research and Clinical Oncology|September 10, 1999

Phase I/II trial of human recombinant granulocyte-colony-stimulating factor (filgrastim) and escalating doses of cyclophosphamide, mitoxantrone, and 5-FU in the treatment of advanced breast cancerG T Budd, J Atiba, R T Silver, et al.

Pageof 89

Showing results (491-500 of 888) with videos related to

Sort By:

Pageof 89

World Journal of Gastroenterology|July 5, 2005

Hydrogen sulfide protects colon cancer cells from chemopreventative agent beta-phenylethyl isothiocyanate induced apoptosisPeter Rose, Philip-K Moore, Shen-Han Ming, et al.

Annals of the Royal College of Surgeons of England|January 1, 1993

Will screening for breast cancer reduce mortality? Evidence from the first year of screening in AvonS Nicholson, A J Webb, B Coghlan, et al.

Traffic (Copenhagen, Denmark)|November 4, 2004

Ncr1p, the yeast ortholog of mammalian Niemann Pick C1 protein, is dispensable for endocytic transportShaochong Zhang, Jihui Ren, Hongzhe Li, et al.

Malaria Journal|March 20, 2013

T1BT* structural study of an anti-plasmodial peptide through NMR and molecular dynamicsElena Topchiy, Geoffrey S Armstrong, Katherine I Boswell, et al.

The Journal of Biological Chemistry|April 19, 2014

Residue histidine 50 plays a key role in protecting α-synuclein from aggregation at physiological pHYing-Chih Chi, Geoffrey S Armstrong, David N M Jones, et al.

Acta Radiologica (Stockholm, Sweden : 1987)|March 1, 1994

Ultrasonographic abdominal screening of atomic bomb-exposed subjectsW J Russell, Y Higashi, T Fukuya, et al.

Anaesthesia and Intensive Care|October 1, 1993

The Australian Incident Monitoring Study. Which monitor? An analysis of 2000 incident reportsR K Webb, J H van der Walt, W B Runciman, et al.

Vox Sanguinis|January 1, 1989

Influence of blood storage time and plasma histamine levels on the pattern of transfusion reactionsD B Frewin, J R Jonsson, C R Frewin, et al.

Antimicrobial Agents and Chemotherapy|February 2, 2011

Activity of ACHN-490 tested alone and in combination with other agents against Pseudomonas aeruginosaGlenn A Pankuch, Gengrong Lin, Aya Kubo, et al.

Journal of Cancer Research and Clinical Oncology|September 10, 1999

Phase I/II trial of human recombinant granulocyte-colony-stimulating factor (filgrastim) and escalating doses of cyclophosphamide, mitoxantrone, and 5-FU in the treatment of advanced breast cancerG T Budd, J Atiba, R T Silver, et al.

Pageof 89